Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation.

Nakano T, Shiizaki K, Miura Y, Matsui M, Kosaki K, Mori S, Yamagata K, Maeda S, Kishi T, Usui N, Yoshida M, Onaka T, Mizukami H, Kaneda R, Karasawa K, Nitta K, Kurosu H, Kuro-O M.

Sci Rep. 2019 Dec 17;9(1):19247. doi: 10.1038/s41598-019-55643-4.

2.

Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae ST258 isolated from a Japanese patient without a history of foreign travel - a new public health concern in Japan: a case report.

Ainoda Y, Aoki K, Ishii Y, Okuda K, Furukawa H, Manabe R, Sahara T, Nakamura-Uchiyama F, Kurosu H, Ando Y, Fujisawa M, Hoshino H, Arima H, Ohnishi K.

BMC Infect Dis. 2019 Jan 7;19(1):20. doi: 10.1186/s12879-018-3649-9.

3.

The Body-wide Transcriptome Landscape of Disease Models.

Kozawa S, Ueda R, Urayama K, Sagawa F, Endo S, Shiizaki K, Kurosu H, Maria de Almeida G, Hasan SM, Nakazato K, Ozaki S, Yamashita Y, Kuro-O M, Sato TN.

iScience. 2018 Apr 27;2:238-268. doi: 10.1016/j.isci.2018.03.014. Epub 2018 Mar 29.

4.

Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease.

Miura Y, Iwazu Y, Shiizaki K, Akimoto T, Kotani K, Kurabayashi M, Kurosu H, Kuro-O M.

Sci Rep. 2018 Jan 19;8(1):1256. doi: 10.1038/s41598-018-19677-4.

5.

Subcellular dissemination of prothymosin alpha at normal physiology: immunohistochemical vis-a-vis western blotting perspective.

Kijogi CM, Khayeka-Wandabwa C, Sasaki K, Tanaka Y, Kurosu H, Matsunaga H, Ueda H.

BMC Physiol. 2016 Mar 1;16:2. doi: 10.1186/s12899-016-0021-4.

6.

Sharp injuries in Japanese operating theaters of HIV/AIDS referral hospitals 2009-2011.

Wada K, Yoshikawa T, Lee JJ, Mitsuda T, Kidouchi K, Kurosu H, Morisawa Y, Aminaka M, Okubo T, Kimura S, Moriya K.

Ind Health. 2016 Jun 10;54(3):224-9. doi: 10.2486/indhealth.2015-0066. Epub 2015 Dec 1.

7.

Incidence rate of needlestick and sharps injuries in 67 Japanese hospitals: a national surveillance study.

Yoshikawa T, Wada K, Lee JJ, Mitsuda T, Kidouchi K, Kurosu H, Morisawa Y, Aminaka M, Okubo T, Kimura S, Moriya K.

PLoS One. 2013 Oct 30;8(10):e77524. doi: 10.1371/journal.pone.0077524. eCollection 2013.

8.

Unusual preservation of fossil mantis shrimp (Stomatopoda): occurrence of mandibles from the Pleistocene Ogushi Formation, Kyushu, Japan.

Ando Y, Ugai H, Kawano S, Nakatani D, Kurosu H, Karasawa H.

Zootaxa. 2013;3691:291-4. No abstract available.

PMID:
26167584
9.

Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.

Goetz R, Ohnishi M, Kir S, Kurosu H, Wang L, Pastor J, Ma J, Gai W, Kuro-o M, Razzaque MS, Mohammadi M.

J Biol Chem. 2012 Aug 17;287(34):29134-46. doi: 10.1074/jbc.M112.342980. Epub 2012 Jun 25.

10.

Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands.

Goetz R, Ohnishi M, Ding X, Kurosu H, Wang L, Akiyoshi J, Ma J, Gai W, Sidis Y, Pitteloud N, Kuro-O M, Razzaque MS, Mohammadi M.

Mol Cell Biol. 2012 May;32(10):1944-54. doi: 10.1128/MCB.06603-11. Epub 2012 Mar 26.

11.

Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis.

Sugiura H, Yoshida T, Shiohira S, Kohei J, Mitobe M, Kurosu H, Kuro-o M, Nitta K, Tsuchiya K.

Am J Physiol Renal Physiol. 2012 May 15;302(10):F1252-64. doi: 10.1152/ajprenal.00294.2011. Epub 2012 Feb 15.

12.

Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.

Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi M, Kuro-o M, Mangelsdorf DJ, Kliewer SA.

Mol Endocrinol. 2010 Oct;24(10):2050-64. doi: 10.1210/me.2010-0142. Epub 2010 Jul 28.

13.

Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.

Goetz R, Nakada Y, Hu MC, Kurosu H, Wang L, Nakatani T, Shi M, Eliseenkova AV, Razzaque MS, Moe OW, Kuro-o M, Mohammadi M.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):407-12. doi: 10.1073/pnas.0902006107. Epub 2009 Dec 4.

14.

NaF activates MAPKs and induces apoptosis in odontoblast-like cells.

Karube H, Nishitai G, Inageda K, Kurosu H, Matsuoka M.

J Dent Res. 2009 May;88(5):461-5. doi: 10.1177/0022034509334771.

PMID:
19493891
15.

Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho.

Cha SK, Hu MC, Kurosu H, Kuro-o M, Moe O, Huang CL.

Mol Pharmacol. 2009 Jul;76(1):38-46. doi: 10.1124/mol.109.055780. Epub 2009 Apr 6.

16.

Endocrine fibroblast growth factors as regulators of metabolic homeostasis.

Kurosu H, Kuro-O M.

Biofactors. 2009 Jan-Feb;35(1):52-60. doi: 10.1002/biof.12. Review.

PMID:
19319846
17.

The Klotho gene family as a regulator of endocrine fibroblast growth factors.

Kurosu H, Kuro-O M.

Mol Cell Endocrinol. 2009 Feb 5;299(1):72-8. doi: 10.1016/j.mce.2008.10.052. Epub 2008 Nov 21. Review.

PMID:
19063940
18.

The Klotho gene family and the endocrine fibroblast growth factors.

Kurosu H, Kuro-o M.

Curr Opin Nephrol Hypertens. 2008 Jul;17(4):368-72. doi: 10.1097/MNH.0b013e3282ffd994. Review.

PMID:
18660672
19.

Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1.

Cha SK, Ortega B, Kurosu H, Rosenblatt KP, Kuro-O M, Huang CL.

Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9805-10. doi: 10.1073/pnas.0803223105. Epub 2008 Jul 7.

20.

Formation of molecular glasses and the aggregation in solutions for lanthanum(III), calcium(II), and yttrium(III) complexes of octanoyl-DL-alaninate.

Naren G, Masuda R, Iida M, Harada M, Kurosu H, Suzuki T, Kimura T.

Dalton Trans. 2008 Apr 7;(13):1698-709. doi: 10.1039/b713768k. Epub 2008 Feb 14.

PMID:
18354767
21.

High field 17O solid-state NMR study of alanine tripeptides.

Yamauchi K, Okonogi M, Kurosu H, Tansho M, Shimizu T, Gullion T, Asakura T.

J Magn Reson. 2008 Feb;190(2):327-32. Epub 2007 Nov 9.

PMID:
18060815
22.

High-field 1H MAS and 15N CP-MAS NMR studies of alanine tripeptides and oligomers: distinction of antiparallel and parallel beta-sheet structures and two crystallographically independent molecules.

Suzuki Y, Okonogi M, Yamauchi K, Kurosu H, Tansho M, Shimizu T, Saitô H, Asakura T.

J Phys Chem B. 2007 Aug 2;111(30):9172-8. Epub 2007 Jul 11.

PMID:
17625826
23.

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.

Kurosu H, Choi M, Ogawa Y, Dickson AS, Goetz R, Eliseenkova AV, Mohammadi M, Rosenblatt KP, Kliewer SA, Kuro-o M.

J Biol Chem. 2007 Sep 14;282(37):26687-95. Epub 2007 Jul 10.

24.

BetaKlotho is required for metabolic activity of fibroblast growth factor 21.

Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP, Goetz R, Eliseenkova AV, Mohammadi M, Kuro-o M.

Proc Natl Acad Sci U S A. 2007 May 1;104(18):7432-7. Epub 2007 Apr 23.

25.

Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.

Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, Yu X, White KE, Inagaki T, Kliewer SA, Yamamoto M, Kurosu H, Ogawa Y, Kuro-o M, Lanske B, Razzaque MS, Mohammadi M.

Mol Cell Biol. 2007 May;27(9):3417-28. Epub 2007 Mar 5.

26.

Purification and analysis of RIN family-novel Rab5 GEFs.

Saito K, Kajiho H, Araki Y, Kurosu H, Kontani K, Nishina H, Katada T.

Methods Enzymol. 2005;403:276-83.

PMID:
16473594
27.

Regulation of fibroblast growth factor-23 signaling by klotho.

Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M.

J Biol Chem. 2006 Mar 10;281(10):6120-3. Epub 2006 Jan 25.

28.

Regulation of oxidative stress by the anti-aging hormone klotho.

Yamamoto M, Clark JD, Pastor JV, Gurnani P, Nandi A, Kurosu H, Miyoshi M, Ogawa Y, Castrillon DH, Rosenblatt KP, Kuro-o M.

J Biol Chem. 2005 Nov 11;280(45):38029-34. Epub 2005 Sep 26.

29.

Suppression of aging in mice by the hormone Klotho.

Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M.

Science. 2005 Sep 16;309(5742):1829-33. Epub 2005 Aug 25.

30.
32.

RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway.

Kajiho H, Saito K, Tsujita K, Kontani K, Araki Y, Kurosu H, Katada T.

J Cell Sci. 2003 Oct 15;116(Pt 20):4159-68.

33.

Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8.

Tanaka H, Yoshida T, Miyamoto N, Motoike T, Kurosu H, Shibata K, Yamanaka A, Williams SC, Richardson JA, Tsujino N, Garry MG, Lerner MR, King DS, O'Dowd BF, Sakurai T, Yanagisawa M.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):6251-6. Epub 2003 Apr 28.

34.

Requirement of phosphatidylinositol 3-kinase activation and calcium influx for leukotriene B4-induced enzyme release.

Ito N, Yokomizo T, Sasaki T, Kurosu H, Penninger J, Kanaho Y, Katada T, Hanaoka K, Shimizu T.

J Biol Chem. 2002 Nov 22;277(47):44898-904. Epub 2002 Sep 19.

35.

Cyclosporin A treatment for membranoproliferative glomerulonephritis type II.

Kiyomasu T, Shibata M, Kurosu H, Shiraishi K, Hashimoto H, Hayashidera T, Akiyama Y, Takeda N.

Nephron. 2002 Jul;91(3):509-11.

PMID:
12119488
36.

A novel binding protein composed of homophilic tetramer exhibits unique properties for the small GTPase Rab5.

Saito K, Murai J, Kajiho H, Kontani K, Kurosu H, Katada T.

J Biol Chem. 2002 Feb 1;277(5):3412-8. Epub 2001 Dec 3.

38.

An accessory role of TCRgammadelta (+) cells in the exacerbation of inflammatory bowel disease in TCRalpha mutant mice.

Kawaguchi-Miyashita M, Shimada S, Kurosu H, Kato-Nagaoka N, Matsuoka Y, Ohwaki M, Ishikawa H, Nanno M.

Eur J Immunol. 2001 Apr;31(4):980-8.

39.
40.

Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors.

Katada T, Kurosu H, Okada T, Suzuki T, Tsujimoto N, Takasuga S, Kontani K, Hazeki O, Ui M.

Chem Phys Lipids. 1999 Apr;98(1-2):79-86. Review.

PMID:
10358930
41.
42.

Activation of PI 3-kinase by G protein betagamma subunits.

Hazeki O, Okada T, Kurosu H, Takasuga S, Suzuki T, Katada T.

Life Sci. 1998;62(17-18):1555-9.

PMID:
9585135
43.

Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide.

Kurosu H, Maehama T, Okada T, Yamamoto T, Hoshino S, Fukui Y, Ui M, Hazeki O, Katada T.

J Biol Chem. 1997 Sep 26;272(39):24252-6.

44.

Association of phosphatidylinositol 3-kinase with the proto-oncogene product Cbl upon CD38 ligation by a specific monoclonal antibody in THP-1 cells.

Matsuo T, Hazeki K, Tsujimoto N, Inoue S, Kurosu H, Kontani K, Hazeki O, Ui M, Katada T.

FEBS Lett. 1996 Nov 11;397(1):113-6.

45.
46.
47.

Multiple fistulae of coronary arteries to both ventricles.

Shiota K, Kinoshita M, Kimura N, Kurosu H, Kuwahara K, Mori C.

Jpn Heart J. 1988 Sep;29(5):741-6.

PMID:
3221449
48.

[Significance of serum type III procollagen N-terminal peptide in patients with fibrotic lung disease].

Tanigawa S, Kinoshita Y, Kurosu H, Mogi M, Masutani M, Hayashi H, Okayasu M.

Nihon Kyobu Shikkan Gakkai Zasshi. 1987 Nov;25(11):1194-201. Japanese. No abstract available.

PMID:
3449674
49.

[Effect of elastase and its inhibitors on the mechanism of development of various pulmonary diseases].

Ichiwata T, Kurosu H, Nakabe S, Iimura F, Kanazawa K, Kobayashi M, Kimoto I, Takeuchi S, Iidoyo S, Uchiyama T, et al.

Nihon Kyobu Shikkan Gakkai Zasshi. 1984 Aug;22(8):636-43. Japanese. No abstract available.

PMID:
6569212
50.

Supplemental Content

Loading ...
Support Center